Pacira | PCRX - Ebit





Ebit Veränderung Datum
Astellas Pharma JPY 132.59B 52.76B 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Cara Therapeutics USD -7.05M 1.11M 2026-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
J&J USD 6.47B 1B 2026-09
Ligand Pharmaceuticals USD 54.53M 2.1M 2026-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Novo Nordisk DKK 33.76B 25.86B 2026-06
Omeros USD -48.15M 7.25M 2023-09
Pacira USD 2.57B 2.56B 2026-09
Perrigo USD 27.2M 116.6M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
Teva Pharmaceutical Industries USD 1.19B 954M 2026-09
Xeris Pharmaceuticals USD -24.15M 33.27M 2026-06
Zoetis USD 1.03B 88M 2026-09